Navigation Links
Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
Date:8/27/2007

work through the recently discovered cellular mechanism known as RNA interference, or RNAi. Quark is able to discover novel therapeutic targets based on its proprietary gene discovery platform, BiFAR(TM). This, combined with its ability to design and successfully deliver synthetic molecules of the new class of RNAi therapeutics known as small-interfering RNA, or siRNA, to specific organs in the body, enables the Company to rapidly develop drug candidates. Quark has two internally discovered and developed lead candidates: RTP801i-14 in Phase 1 clinical trial for the treatment of wet age-related macular degeneration, and AKIi-5 for the prevention of acute renal failure. The Company has out-licensed certain siRNA drug candidates to Pfizer on an exclusive worldwide basis. These drug candidates are designed to inhibit Quark's proprietary target gene RTP801, including RTP801i-14. Quark has, in addition, a product candidate portfolio of RNAi therapeutics based on novel targets and therapeutic concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs of the body.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available on the Company website at http://www.quarkpharma.com.

Forward-looking statement

Various statements in this release concerning the Company's future expectations, plans and prospects, including its intention to publicly offer shares of its common stock, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to fluctuations in our sto
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co., Ltd. ("Guizhou Taibang") entered ... Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to ... to source no less than 500 tonnes of ...
(Date:9/2/2015)... Quebec , Sept. 2, 2015  Valeant Pharmaceuticals ... today announced that its affiliate has entered into a ... USA , Inc. (NASDAQ: SURG ) ... the upfront cash payment, Synergetics stockholders will receive additional ... specified sales milestones are achieved following the closing.  The ...
(Date:9/2/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... participate in the upcoming 17 th Annual Rodman ... at the St. Regis Hotel in New York City.  ... and Chief Executive Officer, will present a corporate overview ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Delcath To Present At The 17th Annual Rodman & Renshaw Conference 2Delcath To Present At The 17th Annual Rodman & Renshaw Conference 3
... 20, 2011 Perrigo Company (Nasdaq: PRGO; TASE) today ... acquire substantially all of the assets of Paddock Laboratories, ... generic pharmaceutical products for approximately $540 million in cash. ... a result of the acquisition of Paddock,s assets. The ...
... Jan. 20, 2011 Reportlinker.com announces that a ... catalogue: Hospital Angiography Census ... is the most comprehensive European market report on ... Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3
(Date:9/2/2015)... ... , ... Good health and a good cause paired up at The Barclays ... donated $11,000 to the New Jersey Golf Foundation through its Healthy Steps Challenge. ... Barclays, Horizon BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to add ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since ... Healthcare of Atlanta to help support childhood cancer research. On June 17, ... WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China ... international investment and business conference will be hosted at five star Beijing Kunlun ... full-weekend networking conference will feature leading EB-5 industry professionals and Chinese private equity ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based ... GROUP is internationally known as an industry leader specializing in surplus used medical ... selling more than 100,000 pieces of medical equipment every year. Erik Tivin, Chairman ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured on NewsWatch as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... comfortably hold a tablet while reducing the likelihood of it dropping. , Tablets like ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2
... shed light on why black women more likely to die, ... The racial gap in breast cancer outcomes, with black women ... completely by any one factor, new research shows. , , ... of the so-called race gap in certain cancers. The racial ...
... CHICAGO, July 7 Finding a simple way to eat ... Barilla "That,s Whole Grain?" Taste Challenge, pasta lovers are invited ... now until December 31, 2009, anyone who tries and is ... free box of their favorite regular Barilla pasta. , ...
... Riverside Partners, based in Boston, Mass., is pleased to ... in Vocollect, Inc. This investment is designed to accelerate ... geographic expansion and product development efforts, as well as ... beyond supply chain and healthcare. , , Vocollect ...
... /PRNewswire/ -- The VAP(R) Cholesterol Test recently ... nine steps to a longer life. TRANSCEND: Nine Steps ... Terry Grossman, M.D., and world-renowned futurist Ray Kurzweil, identifies the ... in cardiovascular risk assessment. , , Grossman, the book,s ...
... who invented a device to measure intrinsic hand ... their patent-pending creation, PRIME. The device could revolutionize ... neurological disorders, specifically carpal tunnel syndrome. The ... IShow, an innovation competition for graduate and undergraduate ...
... ... Century (The Collaboration) announced today the availability of a major new ... a free drug card that will help all Arizonans lower their ... visiting http://www.SavingsDrugCard.com and can immediately start saving up to ...
Cached Medicine News:Health News:New Clues to Race Gap in Breast Cancer Outcomes 2Health News:New Clues to Race Gap in Breast Cancer Outcomes 3Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 2Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 3Health News:Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management 2Health News:Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management 3Health News:VAP(R) Cholesterol Test Highlighted in Groundbreaking Book on Longevity 2Health News:VAP(R) Cholesterol Test Highlighted in Groundbreaking Book on Longevity 3Health News:Rice University team's award-winning device could benefit treatment of hand injuries 2Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 2Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 3
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... viscoelastic insert runs alongside the Achilles ... and targeted intermittent compression during movement. ... irritation of the Achilles tendon is ... wedge (raises heel about 6 mm). ...
... while maintaining the ankle in functional alignment. ... soft, cushioning AliPlast™ foam liner. The cushioning ... the heel in a protective hammock, reducing ... in bed from side-lying to supine. Only ...
... combines the therapeutic benefits of controlled compression ... to minimize pain. The cuff is anatomically ... maximum cryotherapy. The Ankle Cryo/Cuff is one-size ... a pediatric size.,All Cryo/Cuffs can be ordered ...
Medicine Products: